首页 › 基金 › venBio Partners LLC › ALMS
venBio Partners LLC 对 ALMS 的持仓历史
ALUMIS INC · 医疗保健
venBio Partners LLC 在 Q3 2026 的 13F 申报中披露持有 ALMS(ALUMIS INC)4,191,408 股,市值约 US$31.0M,约占其申报组合的 6.25%,在其申报持仓中市值排名第 5 位。 venBio Partners LLC 最近 10 个申报季度中有 10 个季度披露了 ALMS 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
venBio Partners LLC 对 ALMS 的持仓演变
venBio Partners LLC 于 Q2 2024 首次披露 ALMS 持仓:2,826,048 股(约 US$37.6M)。 该持仓在 Q2 2026 达到峰值 4,528,408 股,市值约 US$127.4M。 在 10 次申报中,venBio Partners LLC 1 次增持、3 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 4,191,408 股、市值约 US$31.0M,环比减持 -337,000 股。。 持仓曾出现大幅变动:Q2 2025 增持约 66% (随后一个季度股价上涨 33%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 2.83M | $37.59M | 新进 |
| Q3 2024 | 2.83M | $30.18M | 持有 |
| Q4 2024 | 2.79M | $21.91M | 减持 |
| Q1 2025 | 2.79M | $17.11M | 持有 |
| Q2 2025 | 4.62M | $13.86M | 增持 |
| Q3 2025 | 4.62M | $18.43M | 持有 |
| Q4 2025 | 4.62M | $45.09M | 持有 |
| Q1 2026 | 4.53M | $99.76M | 减持 |
| Q2 2026 | 4.53M | $127.43M | 持有 |
| Q3 2026 | 4.19M | $30.97M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ALMS 与 13F 数据
ALMS(ALUMIS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 ALMS,申报仓位最大的包括:AyurMaya Capital Management Company, LP (US$111.9M), Deep Track Capital, LP (US$55.2M), Samsara BioCapital, LLC (US$53.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ALMS 的基金
- AyurMaya Capital Management Company, LP 15.14M 股 · $111.88M · Q3 2026
- Deep Track Capital, LP 7.47M 股 · $55.20M · Q3 2026
- Samsara BioCapital, LLC 7.24M 股 · $53.47M · Q3 2026
- Foresite Capital Management V, LLC 5.90M 股 · $43.58M · Q3 2026
- Nextech Invest Ltd. 4.55M 股 · $33.63M · Q3 2026
- Foresite Capital Management VI LLC 4.25M 股 · $31.39M · Q3 2026
- Saturn V Capital Management LP 2.86M 股 · $21.10M · Q3 2026
- Opaleye Management Inc. 550.00K 股 · $15.48M · Q2 2026
- Cormorant Asset Management, LP 2.08M 股 · $15.33M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.96M 股 · $14.48M · Q3 2026
- Novo Holdings A/S 1.25M 股 · $9.24M · Q3 2026
- Logos Global Management LP 1.00M 股 · $7.39M · Q3 2026
更多关于 venBio Partners LLC
常见问题
How long has venBio Partners LLC held ALMS?
venBio Partners LLC has disclosed ALMS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is venBio Partners LLC's current position in ALMS?
As of Q3 2026, venBio Partners LLC holds 4.19M shares of ALMS (ALUMIS INC), valued at $30.97M, representing 6.25% of its reported portfolio and ranking #5.
Has venBio Partners LLC been buying or selling ALMS?
In the latest 13F filing (Q3 2026), venBio Partners LLC reduced its position in ALMS. The position peaked in Q2 2026 at 4.53M shares.
Which other funds hold ALMS?
Other major institutional holders of ALMS include AyurMaya Capital Management Company, LP, Deep Track Capital, LP, Samsara BioCapital, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.